» Articles » PMID: 36612099

CRAC and SK Channels: Their Molecular Mechanisms Associated with Cancer Cell Development

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2023 Jan 8
PMID 36612099
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer represents a major health burden worldwide. Several molecular targets have been discovered alongside treatments with positive clinical outcomes. However, the reoccurrence of cancer due to therapy resistance remains the primary cause of mortality. Endeavors in pinpointing new markers as molecular targets in cancer therapy are highly desired. The significance of the co-regulation of Ca-permeating and Ca-regulated ion channels in cancer cell development, proliferation, and migration make them promising molecular targets in cancer therapy. In particular, the co-regulation of the Orai1 and SK3 channels has been well-studied in breast and colon cancer cells, where it finally leads to an invasion-metastasis cascade. Nevertheless, many questions remain unanswered, such as which key molecular components determine and regulate their interplay. To provide a solid foundation for a better understanding of this ion channel co-regulation in cancer, we first shed light on the physiological role of Ca and how this ion is linked to carcinogenesis. Then, we highlight the structure/function relationship of Orai1 and SK3, both individually and in concert, their role in the development of different types of cancer, and aspects that are not yet known in this context.

Citing Articles

S-acylation of Ca transport proteins in cancer.

Kouba S, Demaurex N Chronic Dis Transl Med. 2024; 10(4):263-280.

PMID: 39429488 PMC: 11483607. DOI: 10.1002/cdt3.146.


Synthetic Biology Meets Ca Release-Activated Ca Channel-Dependent Immunomodulation.

Bacsa B, Hopl V, Derler I Cells. 2024; 13(6.

PMID: 38534312 PMC: 10968988. DOI: 10.3390/cells13060468.


The Bis(1,2,3,4-tetrahydroisoquinoline) Alkaloids Cepharanthine and Berbamine Are Ligands of SK Channels.

Vitello R, Taouba H, Derand M, Liegeois J ACS Med Chem Lett. 2024; 15(2):215-220.

PMID: 38352826 PMC: 10860169. DOI: 10.1021/acsmedchemlett.3c00452.


Cannabigerolic Acid (CBGA) Inhibits the TRPM7 Ion Channel Through its Kinase Domain.

Suzuki S, Wakano C, Monteilh-Zoller M, Cullen A, Fleig A, Penner R Function (Oxf). 2024; 5(1):zqad069.

PMID: 38162115 PMC: 10757070. DOI: 10.1093/function/zqad069.

References
1.
Duffy S, Ashmole I, Smallwood D, Leyland M, Bradding P . Orai/CRACM1 and KCa3.1 ion channels interact in the human lung mast cell plasma membrane. Cell Commun Signal. 2015; 13:32. PMC: 4504158. DOI: 10.1186/s12964-015-0112-z. View

2.
Prevarskaya N, Ouadid-Ahidouch H, Skryma R, Shuba Y . Remodelling of Ca2+ transport in cancer: how it contributes to cancer hallmarks?. Philos Trans R Soc Lond B Biol Sci. 2014; 369(1638):20130097. PMC: 3917351. DOI: 10.1098/rstb.2013.0097. View

3.
Semenza G . Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends Pharmacol Sci. 2012; 33(4):207-14. PMC: 3437546. DOI: 10.1016/j.tips.2012.01.005. View

4.
DAlessandro G, Limatola C, Catalano M . Functional Roles of the Ca2+-activated K+ Channel, KCa3.1, in Brain Tumors. Curr Neuropharmacol. 2017; 16(5):636-643. PMC: 5997864. DOI: 10.2174/0929867324666170713103621. View

5.
Waldherr L, Tiffner A, Mishra D, Sallinger M, Schober R, Frischauf I . Blockage of Store-Operated Ca Influx by Synta66 is Mediated by Direct Inhibition of the Ca Selective Orai1 Pore. Cancers (Basel). 2020; 12(10). PMC: 7600887. DOI: 10.3390/cancers12102876. View